» Articles » PMID: 31238913

PFOS Mediates Immunomodulation in an Avian Cell Line That Can Be Mitigated Via a Virus Infection

Overview
Journal BMC Vet Res
Publisher Biomed Central
Date 2019 Jun 27
PMID 31238913
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Per- and polyfluoroalkyl substances (PFASs) are environmentally persistent and bioaccumulative chemicals. Immunomodulation is among the most concerning of toxic effects linked with PFAS exposure in mammalian models. However, no studies had yet shown this to be true in birds. Thus, we designed and conducted the first study to determine if PFASs could cause immunomodulation in birds. Secondly, we wanted to determine the effects on an avian host when exposed not only to immunomodulating chemicals, but also to a viral challenge. The aim, to determine if PFAS mediated immunmodulation functionally affects a pathogen challenge for a host. As innate immune system signalling pathways initiate crucial responses against a pathogen challenge, and are lesser studied than their adaptive counterparts, we focused on these pathways. To provide the first information on this, an in vitro experiment was designed and performed using chicken embryo fibroblasts exposed to perfluorooctane sulfonate (PFOS) (22 ppm) and immune markers characterised before and after being infected with gallid herpesvirus-2 (GaHV-2).

Results: The expression of two pro-inflammatory cytokines, namely interleukin 8 (IL-8) and tumor necrosis factor alpha (TNF-α), the nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB), and the anti-inflammatory cytokine interleukin 4 (IL-4) were investigated in various scenarios. These results showed that exposure to PFOS decreased immune gene expression in chicken fibroblasts from 36 h post-exposure. Next, it was shown that this decrease could be mitigated by infection with gallid herpesvirus-2, which increased gene expression back to the baseline/control levels.

Conclusions: Not only is this the first study to provide the expected evidence that PFOS has immunomodulatory potential in birds, it also provides unexpected data that virus infections can mitigate this negative effect. Thereby, further research, including in vivo and in situ studies, on the impact of PFOS on host-virus interactions is now warranted, as it has been overlooked and might contribute to our understanding of recent disease outbreaks in wildlife. The mechanisms by which gallid herpesvirus mitigates immunomodulation were beyond the scope of this study, but are now of interest for future study.

Citing Articles

Environmental pollutant risk factors for worse COVID-19 related clinical outcomes in predominately hispanic and latino populations.

Baumert B, Wang H, Samy S, Park S, Lam C, Dunn K Environ Res. 2024; 252(Pt 4):119072.

PMID: 38729411 PMC: 11198996. DOI: 10.1016/j.envres.2024.119072.


Per- and polyfluoroalkyl substances alter innate immune function: evidence and data gaps.

Phelps D, Connors A, Ferrero G, DeWitt J, Yoder J J Immunotoxicol. 2024; 21(1):2343362.

PMID: 38712868 PMC: 11249028. DOI: 10.1080/1547691X.2024.2343362.


Evaluation of Neural Regulation and Microglial Responses to Brain Injury in Larval Zebrafish Exposed to Perfluorooctane Sulfonate.

Paquette S, Martin N, Rodd A, Manz K, Allen E, Camarillo M Environ Health Perspect. 2023; 131(11):117008.

PMID: 37966802 PMC: 10650473. DOI: 10.1289/EHP12861.


Effects of exposure to environmentally relevant concentrations of lead (Pb) on expression of stress and immune-related genes, and microRNAs in shorthorn sculpins (Myoxocephalus scorpius).

Jantawongsri K, Norregaard R, Bach L, Dietz R, Sonne C, Jorgensen K Ecotoxicology. 2022; 31(7):1068-1077.

PMID: 36006498 PMC: 9458575. DOI: 10.1007/s10646-022-02575-x.


Primary Cell Lines From Feathers and Blood of Free-Living Tawny Owls (Strix aluco): A New Tool for Non-Lethal Toxicological Studies.

Kroglund I, Eide S, Ostnes J, Kroglund R, Frisli J, Waugh C Front Genet. 2022; 13:856766.

PMID: 35651947 PMC: 9149357. DOI: 10.3389/fgene.2022.856766.

References
1.
Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G . IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins. J Immunol. 2004; 172(9):5467-77. DOI: 10.4049/jimmunol.172.9.5467. View

2.
Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M . In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol. 2011; 258(2):248-55. DOI: 10.1016/j.taap.2011.11.004. View

3.
Goudarzi H, Miyashita C, Okada E, Kashino I, Chen C, Ito S . Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4years of age. Environ Int. 2017; 104:132-138. DOI: 10.1016/j.envint.2017.01.024. View

4.
Osterrieder N, Kamil J, Schumacher D, Tischer B, Trapp S . Marek's disease virus: from miasma to model. Nat Rev Microbiol. 2006; 4(4):283-94. DOI: 10.1038/nrmicro1382. View

5.
Akira S, Sato S . Toll-like receptors and their signaling mechanisms. Scand J Infect Dis. 2003; 35(9):555-62. DOI: 10.1080/00365540310015683. View